Picture of Pharvaris NV logo

PHVS Pharvaris NV News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Founder Jochen Knolle To Transition As Strategic Advisor To CEO

Jan 5 (Reuters) - Pharvaris NV  PHVS.O :
    * PHARVARIS PROVIDES BUSINESS UPDATE AND OUTLINES 2024
STRATEGIC
PRIORITIES
    * PHARVARIS NV - JOCHEN KNOLLE, PH.D., TO TRANSITION TO
STRATEGIC
ADVISOR TO CEO AND EXECUTIVE COMMITTEE
    * PHARVARIS NV - RAPIDE-3, A GLOBAL PHASE 3 CLINICAL STUDY
OF
DEUCRICTIBANT FOR ON-DEMAND TREATMENT OF HAE, TO INITIATE WITHIN
1H24
    * PHARVARIS NV: CLOSING OF $300 MILLION UNDERWRITTEN
OFFERING
EXTENDS CASH RUNWAY
    * PHARVARIS NV - PHARVARIS REMAINS DILIGENT IN ITS
OPERATIONAL
MANAGEMENT AND NOW HAS A CASH RUNWAY FOR AT LEAST TWO YEARS.

Source text for Eikon:  ID:nGNX27nrSV 
Further company coverage:  PHVS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Pharvaris NV

See all news